Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of May 13, 2025 • 7:01 PM ET

Date/Time Source News Release
03/27/2024 09:00 AM EDT GlobeNewswire VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024
02/20/2024 09:00 AM EST GlobeNewswire AXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation
12/20/2023 09:00 AM EST GlobeNewswire AXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production
09/12/2023 09:00 AM EDT Business Wire AXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson's Disease
08/01/2023 09:00 AM EDT Business Wire AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test
07/12/2023 01:36 PM EDT GlobeNewswire Update: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
07/12/2023 09:00 AM EDT GlobeNewswire AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
05/24/2023 09:52 AM EDT GlobeNewswire AXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform Launch
05/23/2023 09:00 AM EDT GlobeNewswire AXIM® Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing Unit
04/11/2023 09:00 AM EDT GlobeNewswire AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
Page

Additional News

As of May 13, 2025 • 7:01 PM ET

Date/Time Source News Release
05/29/2024 09:03 AM EDT NewMediaWire AXIM Biotechnologies Receives Medical Device Manufacturing License
02/20/2024 09:06 AM EST NewMediaWire AXIM Biotechnologies Tear Based Testing Platform Continues to Gain Traction After Successful Clinical Validation
12/20/2023 09:07 AM EST NewMediaWire AXIM Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay Production
10/04/2022 12:23 PM EDT SeekingAlpha Axim stock rises 11% on diagnostic tests order with partner Verséa
09/21/2021 09:12 AM EDT SeekingAlpha AXIM Biotechnologies appoints chief medical officer
05/26/2021 09:32 AM EDT SeekingAlpha AXIM completes pre-clinical studies on SPX-1009 in suppression of melanoma cells
03/08/2021 09:08 AM EST SeekingAlpha AXIM completes point-of-care trials for ImmunoPass COVID-19 test
02/03/2021 09:30 AM EST SeekingAlpha AXIM Biotechnologies begins trials on Immunopass rapid diagnostic test
12/15/2020 11:42 AM EST SeekingAlpha AXIM files amended EUA for diagnostic test for COVID-19 neutralizing antibodies
09/30/2020 09:44 AM EDT SeekingAlpha AXIM files patent for virus binding recombinant protein for SARS-CoV-2
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.